EUVIMEDEUVIMED entdecken
VergleichsstudieQuerschnittstudieOpen Access · CC BY-NC-ND 4.0

Patient-relevance of outcome measures in breast cancer clinical trials: a cross-sectional comparative analysis of patient preferences and trials conducted between 2014 and 2024

Jasmijn Plooij, Diana M J Delnoij

Expert Review of Pharmacoeconomics & Outcomes Research · 2025

DOI: 10.1080/14737167.2025.2467379 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Expert Review of Pharmacoeconomics & Outcomes Research, 2025. Verfasst von Jasmijn Plooij und 1 weiteren Autor:innen. Beteiligte Einrichtung: Erasmus School of Health Policy & Management, Erasmus University Rotterdam, Rotterdam, The Netherlands. Hauptthemen laut MEDLINE: Patient Preference, Breast Neoplasms, Antineoplastic Agents, Outcome Assessment, Health Care. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Patient PreferenceBreast NeoplasmsAntineoplastic AgentsOutcome Assessment, Health CareHumansQuality of LifeFemaleCross-Sectional StudiesClinical Trials, Phase III as TopicResearch DesignProgression-Free SurvivalTreatment Outcome

Stichwörter der Autor:innen

Breast cancerclinical trialsdrug developmentpatient-reported outcomessurrogate outcomes

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Erasmus School of Health Policy & Management, Erasmus University Rotterdam, Rotterdam, The Netherlands.
  • National Health Care Institute, Diemen, The Netherlands.

Zitieren

APA

Plooij, J., & Delnoij, D. M. J. (2025). Patient-relevance of outcome measures in breast cancer clinical trials: a cross-sectional comparative analysis of patient preferences and trials conducted between 2014 and 2024. Expert Review of Pharmacoeconomics & Outcomes Research. https://doi.org/10.1080/14737167.2025.2467379

Vancouver

Plooij J, Delnoij DMJ. Patient-relevance of outcome measures in breast cancer clinical trials: a cross-sectional comparative analysis of patient preferences and trials conducted between 2014 and 2024. Expert Review of Pharmacoeconomics & Outcomes Research. 2025. doi:10.1080/14737167.2025.2467379

BibTeX
@article{Plooij2025,
  author = {Plooij, Jasmijn and Delnoij, Diana M J},
  title = {Patient-relevance of outcome measures in breast cancer clinical trials: a cross-sectional comparative analysis of patient preferences and trials conducted between 2014 and 2024},
  journal = {Expert Review of Pharmacoeconomics & Outcomes Research},
  year = {2025},
  doi = {10.1080/14737167.2025.2467379}
}
Kostenlos starten →